Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status
Faculty
Min P. Kim, MD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Arlene M. Correa, PhD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Jared Lee, MS
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
David C. Rice, MB, BCh
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Jack A. Roth, MD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Reza J. Mehran, MD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Garrett L. Walsh, MD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Jaffer A. Ajani, MD
Department of Gastrointestinal Medical Oncology,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Dipen M. Maru, MD
Department of Pathology,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Joe Y. Chang, MD, PhD
Department of Radiation Oncology,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Edith M. Marom, MD
Department of Diagnostic Radiology,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Homer A. Macapinlac, MD
Department of Nuclear Medicine,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Jeff H. Lee, MD
Department of Gastroenterology, Hepatology and Nutrition,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Ara A. Vaporciyan, MD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Thomas Rice, MD
Department of Thoracic and Cardiovascular Surgery,
Cleveland Clinic, Cleveland, Ohio
Stephen G. Swisher, MD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Wayne L. Hofstetter, MD
Department of Thoracic and Cardiovascular Surgery,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Accredited by
The Society of Thoracic Surgeons
View Activity Materials
Course Description
After reading this article, the learner should be able to:
• describe clinical characteristics unique to the ypT0N1 esophageal cancer group
• characterize the discrepancy between clinical staging and pathologic staging after completion of induction therapy for esophageal cancer
• describe estimated survival for patients with ypT0N1 esophageal cancer after trimodality therapy
• compare survival for patients with ypT0N1 esophageal cancer to those with pCR and pPR
• describe the tumor recurrence pattern for patients with ypT0N1 esophageal cancer
Activity Details
| Credit Types: | CME |
| Credit Amount: | 1.0 Credits |
| Release Date: | 2010-Sep-01 |
| Expiration Date: | 2012-Sep-01 |
| Estimated Time for Completion: | 1 hour |
| Registration Required: | Yes |
| Cost: | $374/yr |
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
